A citation-based method for searching scientific literature

Pietro Andrei, Paolo Battuello, Gaia Grasso, Emanuele Rovera, Nicolò Tesio, Alberto Bardelli. Semin Cancer Biol 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas.
Karmele Valencia, Oihane Erice, Kaja Kostyrko, Simone Hausmann, Elizabeth Guruceaga, Anuradha Tathireddy, Natasha M Flores, Leanne C Sayles, Alex G Lee, Rita Fragoso,[...]. J Clin Invest 2020
14
100

Abrogation of ARF6 promotes RSL3-induced ferroptosis and mitigates gemcitabine resistance in pancreatic cancer cells.
Zeng Ye, Qiangsheng Hu, Qifeng Zhuo, Yuemeng Zhu, Guixiong Fan, Mengqi Liu, Qiqing Sun, Zheng Zhang, Wensheng Liu, Wenyan Xu,[...]. Am J Cancer Res 2020
17
100

Mutant KRAS triggers functional reprogramming of tumor-associated macrophages in colorectal cancer.
Huashan Liu, Zhenxing Liang, Chi Zhou, Ziwei Zeng, Fengwei Wang, Tuo Hu, Xiaowen He, Xiaojian Wu, Xianrui Wu, Ping Lan. Signal Transduct Target Ther 2021
6
100

Ferroptosis: an iron-dependent form of nonapoptotic cell death.
Scott J Dixon, Kathryn M Lemberg, Michael R Lamprecht, Rachid Skouta, Eleina M Zaitsev, Caroline E Gleason, Darpan N Patel, Andras J Bauer, Alexandra M Cantley, Wan Seok Yang,[...]. Cell 2012
100

Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes.
Barbara Manzanares-Martin, Arancha Cebrián Aranda, Laura Del Puerto-Nevado, Rafael González, Sonia Solanes, Maria Auxiliadora Gómez-España, Jesús García-Foncillas, Enrique Aranda. J Immunother Cancer 2021
1
100

Panitumumab in patients with KRAS wild-type colorectal cancer after progression on cetuximab.
Raymond C Wadlow, Aram F Hezel, Thomas A Abrams, Lawrence S Blaszkowsky, Charles S Fuchs, Matthew H Kulke, Eunice L Kwak, Jeffrey A Meyerhardt, David P Ryan, Jackie Szymonifka,[...]. Oncologist 2012
60
100

Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer.
Yijun Tian, Kongming Wu, Qian Liu, Na Han, Li Zhang, Qian Chu, Yuan Chen. J Hematol Oncol 2016
35
100

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.
Rafael G Amado, Michael Wolf, Marc Peeters, Eric Van Cutsem, Salvatore Siena, Daniel J Freeman, Todd Juan, Robert Sikorski, Sid Suggs, Robert Radinsky,[...]. J Clin Oncol 2008
100

The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells.
Mami Sato, Ryosuke Kusumi, Shinji Hamashima, Sho Kobayashi, Satoru Sasaki, Yuhei Komiyama, Takuji Izumikawa, Marcus Conrad, Shiro Bannai, Hideyo Sato. Sci Rep 2018
99
100

Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibition.
Teresa Troiani, Stefania Napolitano, Donata Vitagliano, Floriana Morgillo, Anna Capasso, Vincenzo Sforza, Anna Nappi, Davide Ciardiello, Fortunato Ciardiello, Erika Martinelli. Clin Cancer Res 2014
76
100


Andrographolide induces Nrf2 and heme oxygenase 1 in astrocytes by activating p38 MAPK and ERK.
Siew Ying Wong, Michelle G K Tan, Peter T H Wong, Deron R Herr, Mitchell K P Lai. J Neuroinflammation 2016
38
100

Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer.
Annalisa Lorenzato, Alessandro Magrì, Vittoria Matafora, Valentina Audrito, Pamela Arcella, Luca Lazzari, Monica Montone, Simona Lamba, Silvia Deaglio, Salvatore Siena,[...]. Cancers (Basel) 2020
14
100


Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients.
Ilya G Serebriiskii, Caitlin Connelly, Garrett Frampton, Justin Newberg, Matthew Cooke, Vince Miller, Siraj Ali, Jeffrey S Ross, Elizabeth Handorf, Sanjeevani Arora,[...]. Nat Commun 2019
59
100

Induction of HO-1 by 5, 8-Dihydroxy-4',7-Dimethoxyflavone via Activation of ROS/p38 MAPK/Nrf2 Attenuates Thrombin-Induced Connective Tissue Growth Factor Expression in Human Cardiac Fibroblasts.
Chien-Chung Yang, Li-Der Hsiao, Hsin-Hui Lin, Hui-Ching Tseng, Jiro Hasegawa Situmorang, Yann-Lii Leu, Chuen-Mao Yang. Oxid Med Cell Longev 2020
5
100

Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways.
Ping Yao, Andreas Nussler, Liegang Liu, Liping Hao, Fangfang Song, Anja Schirmeier, Natascha Nussler. J Hepatol 2007
246
100

Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer.
Jian-Shu Lou, Li-Ping Zhao, Zhi-Hui Huang, Xia-Yin Chen, Jing-Ting Xu, William Chi-Shing Tai, Karl W K Tsim, Yi-Tao Chen, Tian Xie. Phytomedicine 2021
21
100

Nrf2 protects against seawater drowning-induced acute lung injury via inhibiting ferroptosis.
Yu-Bao Qiu, Bin-Bin Wan, Gang Liu, Ya-Xian Wu, Dan Chen, Mu-Dan Lu, Jun-Liang Chen, Ren-Qiang Yu, Dao-Zhen Chen, Qing-Feng Pang. Respir Res 2020
18
100

Ferroptosis is a type of autophagy-dependent cell death.
Borong Zhou, Jiao Liu, Rui Kang, Daniel J Klionsky, Guido Kroemer, Daolin Tang. Semin Cancer Biol 2020
145
100

RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients.
Umberto Malapelle, Francesco Passiglia, Chiara Cremolini, Maria Lucia Reale, Francesco Pepe, Pasquale Pisapia, Antonio Avallone, Diego Cortinovis, Alfonso De Stefano, Matteo Fassan,[...]. Eur J Cancer 2021
14
100

CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers.
Hae Rim Jung, Yumi Oh, Deukchae Na, Seoyeon Min, Jinjoo Kang, Dongjun Jang, Seungjae Shin, Jiwon Kim, Sang Eun Lee, Eui Man Jeong,[...]. Oncogene 2021
2
100


Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis.
Xiaofang Sun, Xiaohua Niu, Ruochan Chen, Wenyin He, De Chen, Rui Kang, Daolin Tang. Hepatology 2016
199
100

FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer.
L Marzi, E Combes, N Vié, A Ayrolles-Torro, D Tosi, D Desigaud, E Perez-Gracia, C Larbouret, C Montagut, M Iglesias,[...]. Br J Cancer 2016
32
100

NLRP7 deubiquitination by USP10 promotes tumor progression and tumor-associated macrophage polarization in colorectal cancer.
Bing Li, Zhi-Peng Qi, Dong-Li He, Zhang-Han Chen, Jing-Yi Liu, Meng-Wai Wong, Jia-Wei Zhang, En-Pan Xu, Qiang Shi, Shi-Lun Cai,[...]. J Exp Clin Cancer Res 2021
2
100

The development of the concept of ferroptosis.
Tal Hirschhorn, Brent R Stockwell. Free Radic Biol Med 2019
178
100

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
100

Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab.
Stefania Napolitano, Giulia Martini, Barbara Rinaldi, Erika Martinelli, Maria Donniacuo, Liberato Berrino, Donata Vitagliano, Floriana Morgillo, Giusy Barra, Raffaele De Palma,[...]. Clin Cancer Res 2015
51
100

Melatonin Suppresses Ferroptosis Induced by High Glucose via Activation of the Nrf2/HO-1 Signaling Pathway in Type 2 Diabetic Osteoporosis.
Hongdong Ma, Xindong Wang, Weilin Zhang, Haitian Li, Wei Zhao, Jun Sun, Maowei Yang. Oxid Med Cell Longev 2020
16
100

Cysteine Sulfenylation Directs IRE-1 to Activate the SKN-1/Nrf2 Antioxidant Response.
John M Hourihan, Lorenza E Moronetti Mazzeo, L Paulette Fernández-Cárdenas, T Keith Blackwell. Mol Cell 2016
97
100

Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3.
Ryosuke Shintoku, Yuta Takigawa, Keiichi Yamada, Chisato Kubota, Yuhei Yoshimoto, Toshiyuki Takeuchi, Ichiro Koshiishi, Seiji Torii. Cancer Sci 2017
119
100

MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her-2/PI3K/AKT Signaling.
Ying Han, Yinghui Peng, Yaojie Fu, Changjing Cai, Cao Guo, Shanshan Liu, Yiyi Li, Yihong Chen, Edward Shen, Kexin Long,[...]. Adv Sci (Weinh) 2020
7
100


HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer.
Said A Khelwatty, Soozana Puvanenthiran, Sharadah Essapen, Izhar Bagwan, Alan M Seddon, Helmout Modjtahedi. Cancers (Basel) 2021
3
100

Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
Peng Chen, Xuejie Li, Ruonan Zhang, Shuiping Liu, Yu Xiang, Mingming Zhang, Xiaying Chen, Ting Pan, Lili Yan, Jiao Feng,[...]. Theranostics 2020
44
100

Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation.
Jialei Sun, Chenhao Zhou, Yue Zhao, Xiaofei Zhang, Wanyong Chen, Qiang Zhou, Bo Hu, Dongmei Gao, Lisa Raatz, Zhefang Wang,[...]. Redox Biol 2021
8
100

Cancer statistics for the year 2020: An overview.
Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram, Donald M Parkin, Marion Piñeros, Ariana Znaor, Freddie Bray. Int J Cancer 2021
126
100

BRG1 protects the heart from acute myocardial infarction by reducing oxidative damage through the activation of the NRF2/HO1 signaling pathway.
Xiaoping Liu, Xun Yuan, Guanfeng Liang, Shuyun Zhang, Guiping Zhang, Yuan Qin, Qiulian Zhu, Qing Xiao, Ning Hou, Jian-Dong Luo. Free Radic Biol Med 2020
4
100

Broadening horizons: the role of ferroptosis in cancer.
Xin Chen, Rui Kang, Guido Kroemer, Daolin Tang. Nat Rev Clin Oncol 2021
104
100

Cetuximab combined with cisplatin improves the prognosis of gastric cancer patients and its effect on P38 MAPK expression.
Qiang Chen, Longhai Shen, Can Chen, Huan He, Yining Fu, Liang Xu, Yang Wang. J BUON 2019
3
100


Prognostic impact of KRAS mutation status for patients with stage IV adenocarcinoma of the lung treated with first-line pembrolizumab monotherapy.
A L Noordhof, R A M Damhuis, L E L Hendriks, A J de Langen, W Timens, B J W Venmans, W H van Geffen. Lung Cancer 2021
1
100

Cetuximab plus irinotecan administered biweekly with reduced infusion time to heavily pretreated patients with metastatic colorectal cancer and related RAS and BRAF mutation status.
Benny Vittrup Jensen, Jakob V Schou, Mette Yilmaz, Helle H Johannesen, Kristin Skougaard, Dorte Linnemann, Estrid V Hogdall, Finn O Larsen, Julia S Johansen, Per Pfeiffer,[...]. Int J Cancer 2020
1
100

NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis.
Matthew Dodson, Raul Castro-Portuguez, Donna D Zhang. Redox Biol 2019
198
100

Dihydroartemisinin-Loaded Magnetic Nanoparticles for Enhanced Chemodynamic Therapy.
Shengdi Guo, Xianxian Yao, Qin Jiang, Kuang Wang, Yuanying Zhang, Haibao Peng, Jing Tang, Wuli Yang. Front Pharmacol 2020
15
100

Chemoprevention of dietary digitoflavone on colitis-associated colon tumorigenesis through inducing Nrf2 signaling pathway and inhibition of inflammation.
Yang Yang, Xueting Cai, Jie Yang, Xiaoyan Sun, Chunping Hu, Zhanpeng Yan, Xiaojun Xu, Wuguang Lu, Xiaoning Wang, Peng Cao. Mol Cancer 2014
51
100

Prognostic value of KRAS mutation in patients undergoing pulmonary metastasectomy for colorectal cancer: A systematic review and meta-analysis.
Junfeng Huang, Qing Zang, Yaokai Wen, Zhe Pan, Zhiyuan Yao, Mingkai Huang, Jiongqiang Huang, Jingsong Chen, Rongchang Wang. Crit Rev Oncol Hematol 2021
3
100

MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity via EGFR regulation.
Toshinaga Suto, Takehiko Yokobori, Reina Yajima, Hiroki Morita, Takaaki Fujii, Satoru Yamaguchi, Bolag Altan, Souichi Tsutsumi, Takayuki Asao, Hiroyuki Kuwano. Carcinogenesis 2015
90
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.